Economy

UniQure NV - Ordinary Shares (NASDAQ:QURE) Moving Aggressively - Up $0.06

UniQure NV - Ordinary Shares (NASDAQ:QURE) Moving Aggressively - Up $0.06”

uniQure N.V. (NASDAQ:QURE) shares typically trade an average volume of 283.09 and institutions hold 59.90% of the total shares. The company presently has an average rating of "Hold" and a consensus target price of $12.45. The Company?s product candidates include AMT-060 for Hemophilia B, AMT-130 for Huntington's disease, S100A1 for congestive heart failure and Glybera for lipoprotein lipase deficiency (LPLD). uniQure has established clinical proof-of-concept in its lead indication, hemophilia B and has achieved pre-clinical, proof-of-concept in Huntington's disease.

Additionally, according to TipRanks, cautious optimism is circling the biotech firm when looking at Wall Street sentiment, considering that based on 6 analysts polled in the 12 months, half rate a Buy on Uniqure stock while half maintain a Hold. UNIQURE B.V.is headquartered in Amsterdam, the Netherlands. The stock was trading at a distance of -0.87% from its 52-week highs and stands 57.42% away from its 52-week lows. These are called exhaustion moves because typically when so many shares change hands there is no one left to keep pushing the price in the trending direction and it reverses (often quickly). The company now has an average rating of "Hold" and an average target price of $13.54. The analysts estimated EPS for the higher end at -0.48 and lower end at -0.73 while the year ago reported earnings per share was -0.98. The business had revenue of $4.94 million during the quarter, compared to analyst estimates of $2.92 million. The company's market cap is $194.75 million.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & global trademark and copyright law. The stock's quarterly performance indicates a positive momentum of 14.37 percent, whereas its last one month trend is optimistic with 16.05 percent. Renaissance Technologies LLC now owns 374,000 shares of the biotechnology company's stock worth $2,162,000 after buying an additional 122,700 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of uniQure N.V.by 50.5% during the 1st quarter. FMR LLC grew its stake in uniQure N.V.by 4.1% in the 2nd quarter.

The company's diluted EPS for trailing twelve months was -3.01. Finally, Renaissance Technologies LLC lifted its holdings in shares of uniQure N.V.by 48.8% during the 1st quarter.

Investors of this company earned a return of -41.90% on the assets it owns in past twelve month.

Now we take a performance look how uniQure N.V. (QURE) has been performing in different time periods. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company is advancing a focused pipeline of gene therapies that have been developed both internally and through partnerships.



Like this

loading...
loading...

Latest


21 October 2017
Anheuser-Busch Inbev SA's (BUD) "Buy" Rating Reaffirmed at Berenberg Bank
Therefore 64% are positive. (The) reaffirmed a "buy" rating on shares of Anheuser-Busch Inbev SA in a report on Monday, July 10th. The consumer goods maker reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.19).

21 October 2017
Denmark Open Super Series: Saina Nehwal, Srikanth, Prannoy march into quarterfinals
However, Son Wan quickly leveled par with three quick points and took the lead with a measured return at his rival's forecourt. The Denmark shuttler dominated the first game completely but was sent on the back-foot by the Indian in the next two games.

21 October 2017
Analyst Research and Ratings: Six Flags Entertainment Corporation (SIX), The Cheesecake Factory Incorporated (CAKE)
The Cheesecake Factory Incorporated has 46.84 million shares outstanding, and in the last trade has seen ATR around 0.98. Pacad Investment Ltd decreased Manpowergroup Inc (NYSE:MAN) stake by 5,300 shares to 9,900 valued at $1.11M in 2017Q2.

21 October 2017
Lincoln Capital Corp Sells 16075 Shares of Kansas City Southern (KSU)
The share price of Kansas City Southern (NYSE:KSU) was up +1.32% during the last trading session, with a day high of 107.28. WINTON GROUP Ltd purchased a new position in Kansas City Southern in the 2nd quarter valued at approximately $386,000.

21 October 2017
Foo Fighters Release Brand New Song 'Soldier'
This week Foo Fighters announced three stadiums shows set to take place next June, with two nights at London's Olympic Stadium. The song is an outtake from the Concrete and Gold recording sessions but will be released a little differently.

21 October 2017
How Does Helios and Matheson Analytics Inc. (HMNY) Stack Up Right Now?
Financial companies led US stocks higher in midday trading Wednesday, putting the major indexes on track to set new records. These ratios show how well income is generated through operations, and are important to both creditors and investors.

21 October 2017
Elon Musk gets OK to begin digging for Hyperloop project in Maryland
The permit allows Musk's company to dig a 10.3-mile tunnel beneath the state-owned portion of the Baltimore-Washington Parkway. The state said it does not expect to contribute to the building of the project, which will be funded by Musk's companies.

21 October 2017
The Goodyear Tire & Rubber Company (GT) Consensus Earnings Outlook
Rather than make assumptions, investors should carefully read the definitions of all ratings used in each research report. Investors and traders may use this indicator to help spot price reversals, price extremes, and the strength of a trend.

21 October 2017
Panthers LB Kuechly to miss Bears game; Benjamin to play
According to ESPN, he sat at his locker and played loud music during the open media session . Rodrigue was the reporter who Newton laughed at during a press conference back on October 4.

21 October 2017
Gov. Cuomo signs bill to protect circus elephants in NY
"The use of elephants in these types of settings is unsafe to their health and potentially abusive", Governor Cuomo said. New Yorkers have proved that they don't want to see sensitive and complex elephants chained and beaten for circus shows.